|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
DBL -Institute for Health Research and Development Vector control Division, Kampala, Uganda |
| Information provided by: | DBL -Institute for Health Research and Development |
| ClinicalTrials.gov Identifier: | NCT00215280 |
Purpose
Mansonella perstans (M. perstans) infection is widespread in Uganda. Knowledge about the epidemiology of this infection, and of the morbidity it induces is poor, and no effective treatment is available. The study aims at providing data on diagnostic, epidemiological, morbidity and treatment aspects of M. perstans infections in Uganda.
| Condition | Intervention |
|
Mansonelliasis Pruritus Lymphoedema Abdominal Pains |
Drug: ivermectin and albendazole |
| Genetics Home Reference related topics: | lymphedema-distichiasis syndrome |
| MedlinePlus related topics: | Abdominal Pain Itching Lymphedema |
| ChemIDplus related topics: | Albendazole Ivermectin |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study |
| Official Title: | Studies on the Epidemiology and Control of Mansonella Perstans Infection in Uganda |
| Estimated Enrollment: | 1000 |
| Study Start Date: | November 2005 |
| Estimated Study Completion Date: | February 2006 |
Overall objective: to investigate diagnostic, epidemiological and treatment aspects of M. perstans in Uganda with relevance to control
Specific objectives:
Eligibility
| Ages Eligible for Study: | 5 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Uganda, Luwero and Mukono Districts | |||||
| Luwero | |||||
| Luwero and Mukono, Luwero and Mukono Districts, Uganda | |||||
| DBL -Institute for Health Research and Development |
| Vector control Division, Kampala, Uganda |
| Principal Investigator: | Asanta M Asio, Msc | Vector control Division, Kampala, Uganda |
More Information
Related Info 
  |
| Study ID Numbers: | MV917090205 |
| First Received: | September 21, 2005 |
| Last Updated: | April 19, 2007 |
| ClinicalTrials.gov Identifier: | NCT00215280 |
| Health Authority: | Uganda: National Council for Science and Technology |
|
|
|
|
|
|